FPT, a 2-Aminotetralin, Is a Potent Serotonin 5-HT1A, 5-HT1B, and 5-HT1D Receptor Agonist That Modulates Cortical Electroencephalogram Activity in Adult Fmr1 Knockout Mice
出版年份 2022 全文链接
标题
FPT, a 2-Aminotetralin, Is a Potent Serotonin 5-HT1A, 5-HT1B, and 5-HT1D Receptor Agonist That Modulates Cortical Electroencephalogram Activity in Adult Fmr1 Knockout Mice
作者
关键词
-
出版物
ACS Chemical Neuroscience
Volume 13, Issue 24, Pages 3629-3640
出版商
American Chemical Society (ACS)
发表日期
2022-12-07
DOI
10.1021/acschemneuro.2c00574
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Impaired Functional Connectivity Underlies Fragile X Syndrome
- (2022) Lital Gildin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Seizures in Fragile X Syndrome: Associations and Longitudinal Analysis of a Large Clinic-Based Cohort
- (2022) Elizabeth Berry-Kravis et al. Frontiers in Pediatrics
- Spontaneous seizures in adult Fmr1 knockout mice: FVB.129P2-Pde6b+ Tyr Fmr1/J
- (2022) Jessica L. Armstrong et al. EPILEPSY RESEARCH
- Targeting 5‐HT1A Receptors to Correct Neuronal Hyperexcitability in Fmr1 Knockout Mice
- (2022) Tanishka S. Saraf et al. FASEB JOURNAL
- Clozapine’s multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia
- (2022) Andrea de Bartolomeis et al. PHARMACOLOGY & THERAPEUTICS
- The Autism Biomarkers Consortium for Clinical Trials: Initial Evaluation of a Battery of Candidate EEG Biomarkers
- (2022) Sara Jane Webb et al. AMERICAN JOURNAL OF PSYCHIATRY
- Baclofen-associated neurophysiologic target engagement across species in fragile X syndrome
- (2022) Carrie R. Jonak et al. Journal of Neurodevelopmental Disorders
- Non-sedative cortical EEG signatures of allopregnanolone and functional comparators
- (2022) Peter M. Lambert et al. NEUROPSYCHOPHARMACOLOGY
- The PDE10A Inhibitor TAK-063 Reverses Sound-Evoked EEG Abnormalities in a Mouse Model of Fragile X Syndrome
- (2021) Carrie R. Jonak et al. Neurotherapeutics
- Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia
- (2021) Stephen K. Brannan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased aperiodic gamma power in young boys with Fragile X Syndrome is associated with better language ability
- (2021) Carol L. Wilkinson et al. Molecular Autism
- Channelopathies in fragile X syndrome
- (2021) Pan-Yue Deng et al. NATURE REVIEWS NEUROSCIENCE
- Evaluation of lorcaserin as an anticonvulsant in juvenile Fmr1 knockout mice
- (2021) Tanishka S. Saraf et al. EPILEPSY RESEARCH
- Sex differences in resting EEG power in Fragile X Syndrome
- (2021) Elizabeth G. Smith et al. JOURNAL OF PSYCHIATRIC RESEARCH
- A human forebrain organoid model of fragile X syndrome exhibits altered neurogenesis and highlights new treatment strategies
- (2021) Yunhee Kang et al. NATURE NEUROSCIENCE
- Systemic enhancement of serotonin signaling reverses social deficits in multiple mouse models for ASD
- (2021) Jessica J. Walsh et al. NEUROPSYCHOPHARMACOLOGY
- Translating biased agonists from molecules to medications: Serotonin 5-HT1A receptor functional selectivity for CNS disorders
- (2021) Adrian Newman-Tancredi et al. PHARMACOLOGY & THERAPEUTICS
- GABAA Alpha 2,3 Modulation Improves Select Phenotypes in a Mouse Model of Fragile X Syndrome
- (2021) Tori L. Schaefer et al. Frontiers in Psychiatry
- Functional consequences of postnatal interventions in a mouse model of Fragile X syndrome
- (2021) Maham Rais et al. NEUROBIOLOGY OF DISEASE
- EEG Signal Complexity Is Reduced During Resting-State in Fragile X Syndrome
- (2021) Mélodie Proteau-Lemieux et al. Frontiers in Psychiatry
- Neural Correlates of Auditory Hypersensitivity in Fragile X Syndrome
- (2021) Khaleel A. Razak et al. Frontiers in Psychiatry
- Preclinical testing of the ketogenic diet in fragile X mice
- (2020) Pamela R. Westmark et al. NEUROCHEMISTRY INTERNATIONAL
- A 5‐HT 1D ‐Receptor Agonist Protects Dravet Syndrome Mice from Seizure and Early Death
- (2020) Paul G. Hatini et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Acute pharmacological inhibition of matrix metalloproteinase‐9 activity during development restores perineuronal net formation and normalizes auditory processing in Fmr1 KO mice
- (2020) Patricia S. Pirbhoy et al. JOURNAL OF NEUROCHEMISTRY
- Multielectrode array analysis of EEG biomarkers in a mouse model of Fragile X Syndrome
- (2020) Carrie R. Jonak et al. NEUROBIOLOGY OF DISEASE
- Mu Rhythm Separation from the Mix with Alpha Rhythm: Principal Component Analyses and Factor Topography
- (2020) Zhanna Garakh et al. JOURNAL OF NEUROSCIENCE METHODS
- Drug-responsive autism phenotypes in the 16p11.2 deletion mouse model: a central role for gene-environment interactions
- (2020) Emma J. Mitchell et al. Scientific Reports
- Minocycline Treatment Reverses Sound Evoked EEG Abnormalities in a Mouse Model of Fragile X Syndrome
- (2020) Jonathan W. Lovelace et al. Frontiers in Neuroscience
- Sexually dimorphic patterns in electroencephalography power spectrum and autism-related behaviors in a rat model of fragile X syndrome
- (2020) Hayes Wong et al. NEUROBIOLOGY OF DISEASE
- The M1/M4 preferring muscarinic agonist xanomeline modulates functional connectivity and NMDAR antagonist-induced changes in the mouse brain
- (2020) Caterina Montani et al. NEUROPSYCHOPHARMACOLOGY
- Local cortical circuit correlates of altered EEG in the mouse model of Fragile X syndrome
- (2019) Sonal Goswami et al. NEUROBIOLOGY OF DISEASE
- TAK-071, a muscarinic M1 receptor positive allosteric modulator, attenuates scopolamine-induced quantitative electroencephalogram power spectral changes in cynomolgus monkeys
- (2019) Emi Kurimoto et al. PLoS One
- Deletion of Fmr1 from Forebrain Excitatory Neurons Triggers Abnormal Cellular, EEG, and Behavioral Phenotypes in the Auditory Cortex of a Mouse Model of Fragile X Syndrome
- (2019) Jonathan W Lovelace et al. CEREBRAL CORTEX
- Audiogenic Seizures in the Fmr1 Knock-Out Mouse Are Induced by Fmr1 Deletion in Subcortical, VGlut2-Expressing Excitatory Neurons and Require Deletion in the Inferior Colliculus
- (2019) Darya Gonzalez et al. JOURNAL OF NEUROSCIENCE
- Auditory EEG Biomarkers in Fragile X Syndrome: Clinical Relevance
- (2019) Lauren E. Ethridge et al. Frontiers in Integrative Neuroscience
- Synthesis of novel 5-substituted-2-aminotetralin analogs: 5-HT1A and 5-HT7 G protein-coupled receptor affinity, 3D-QSAR and molecular modeling
- (2019) Charles K. Perry et al. BIOORGANIC & MEDICINAL CHEMISTRY
- GABAergic abnormalities in the fragile X syndrome
- (2019) Nathalie Van der Aa et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Translation-relevant EEG phenotypes in a mouse model of Fragile X Syndrome
- (2018) Jonathan W. Lovelace et al. NEUROBIOLOGY OF DISEASE
- Sensory Processing Phenotypes in Fragile X Syndrome
- (2018) Maham Rais et al. ASN Neuro
- Developmental Changes in EEG Phenotypes in a Mouse Model of Fragile X Syndrome
- (2018) Teresa H. Wen et al. NEUROSCIENCE
- Arbaclofen in fragile X syndrome: results of phase 3 trials
- (2017) Elizabeth Berry-Kravis et al. Journal of Neurodevelopmental Disorders
- Fragile X targeted pharmacotherapy: lessons learned and future directions
- (2017) Craig A. Erickson et al. Journal of Neurodevelopmental Disorders
- A resting EEG study of neocortical hyperexcitability and altered functional connectivity in fragile X syndrome
- (2017) Jun Wang et al. Journal of Neurodevelopmental Disorders
- Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment
- (2017) Walter E. Kaufmann et al. PEDIATRICS
- Excitability is increased in hippocampal CA1 pyramidal cells of Fmr1 knockout mice
- (2017) M. Angeles Luque et al. PLoS One
- Fragile X syndrome
- (2017) Randi J. Hagerman et al. Nature Reviews Disease Primers
- Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial
- (2016) Jeremy Veenstra-VanderWeele et al. NEUROPSYCHOPHARMACOLOGY
- An Orally Active Phenylaminotetralin-Chemotype Serotonin 5-HT7 and 5-HT1A Receptor Partial Agonist That Corrects Motor Stereotypy in Mouse Models
- (2015) Clinton E. Canal et al. ACS Chemical Neuroscience
- Altered Neuronal and Circuit Excitability in Fragile X Syndrome
- (2015) Anis Contractor et al. NEURON
- Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine - a quantitative EEG study in rats
- (2014) S C Leiser et al. BRITISH JOURNAL OF PHARMACOLOGY
- Altered auditory processing in a mouse model of fragile X syndrome
- (2013) Sarah Rotschafer et al. BRAIN RESEARCH
- Coherent delta-band oscillations between cortical areas correlate with decision making
- (2013) V. Nacher et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reduced alpha and exaggerated theta power during the resting-state EEG in fragile X syndrome
- (2012) Melle J.W. Van der Molen et al. BIOLOGICAL PSYCHOLOGY
- Association of impaired EEG mu wave suppression, negative symptoms and social functioning in biological motion processing in first episode of psychosis
- (2011) Fiza Singh et al. SCHIZOPHRENIA RESEARCH
- Electromyogenic Artifacts and Electroencephalographic Inferences
- (2009) Alexander J. Shackman et al. BRAIN TOPOGRAPHY
- Increased GABAB Receptor-Mediated Signaling Reduces the Susceptibility of Fragile X Knockout Mice to Audiogenic Seizures
- (2009) L. K. K. Pacey et al. MOLECULAR PHARMACOLOGY
- Imbalance of Neocortical Excitation and Inhibition and Altered UP States Reflect Network Hyperexcitability in the Mouse Model of Fragile X Syndrome
- (2008) Jay R. Gibson et al. JOURNAL OF NEUROPHYSIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now